Doxycycline Taj Pharma has been found clinically effective in the treatment of a variety of infections caused by susceptible strains of Gram-positive and Gram-negative bacteria and certain other micro- organisms.
Respiratory tract infections
Pneumonia and other lower respiratory tract infections due to susceptible strains of Streptococcus pneumoniae, Haemophilus influenzae, Klebsiella pneumoniae and other organisms. Mycoplasma pneumoniae pneumonia. Treatment of chronic bronchitis, sinusitis.
Urinary tract infections
Infections caused by susceptible strains of Klebsiella species, Enterobacter species.
Escherichia coli, Streptococcus faecalis and other organisms.
Sexually transmitted diseases
Infections due to Chlamydia trachomatis including uncomplicated urethral, endocervical or rectal infections. Non-gonococcal urethritis caused by Ureaplasma urealyticum (T- mycoplasma).
Doxycycline Taj Pharma is also indicated in chancroid, granuloma inguinale and lymphogranuloma venereum. Doxycycline Taj Pharma is an alternative drug in the treatment of gonorrhoea and syphilis.
Acne vulgaris when antibiotic therapy is considered necessary.
Since Doxycycline Taj Pharma is a member of the tetracycline group of antibiotics, it may be expected to be useful in the treatment of infections, which respond to other tetracyclines, such as:
Due to susceptible strains of gonococci, staphylococci and Haemophilus influenzae. Doxycycline Taj Pharma Capsules are indicated in the treatment of trachoma, although the infectious agent is not always eliminated, as judged by immunofluorescence.
Rocky Mountain spotted fever, typhus group, Q fever, Coxiella endocarditis and tick fevers.
Psittacosis, cholera, meliodosis, leptospirosis, other infections due to susceptible strains of Yersinia species, Brucella species (in combination with Streptomycin), Clostridium species, Francisella tularensis and chloroquine-resistant falciparum malaria.
Doxycycline Taj Pharma Capsules are indicated for prophylaxis in the following conditions: Scrub typhus, travellers? diarrhoea (enterotoxigenic Escherichia coli), leptospirosis.
Consideration should be given to official guidance on the appropriate use of antibacterial agents.
There are no reviews yet.